Cbd stocks rerated6 Apr 2021 12:02
Knb 15% up , and we are moving like a snail .Mxc has received Ethics committee approval phase 3 clinical trial are being undertaken in Israel on patients diagnosed with covid 19. Mxc is fully funded to complete the trial following the lse ipo raising £6.5 million. The trial will evaluate the efficacy and safety of CimetrATM. Buying mxc at under 4p when sooner than later it will be multiples of today's price..imo... Enjoy ...